Form 13-F position report

CULLINAN ONCOLOGY INC

Reported by ALLIANCEBERNSTEIN L P

CGEM CUSIP 230031106 Manager CIK 0001109448

Reported 15,900 shares, up 2,100 (15.2%) from the prior quarter.

Reported value -21.2%; share count 15.2% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2021
Shares 15,900 Quarter-end amount reported
Reported value $245,000 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 245000
2022-03-31 148000
2022-06-30 312000
2022-09-30 342000
2022-12-31 297510
2023-03-31 334521
2023-06-30 470642
2023-09-30 395847
2023-12-31 442042
2024-03-31 565728
2024-06-30 30145825
2024-09-30 31042823
2024-12-31 24500375
2025-03-31 13043118
2025-06-30 358654
2025-09-30 282446
2025-12-31 492971
2026-03-31 492971
2026-06-30 1069303
2026-09-30 974111

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for CULLINAN ONCOLOGY INC held by ALLIANCEBERNSTEIN L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 63,460 -11,790 (-15.7%) < 0.01% $974,111 2026-11-16
Q2 2026 Added 75,250 +27,620 (58.0%) < 0.01% $1,069,303 2026-08-14
Q1 2026 Unchanged 47,630 0 (0.0%) < 0.01% $492,971 2026-05-15
Q4 2025 Unchanged 47,630 0 (0.0%) < 0.01% $492,971 2026-02-17
Q3 2025 Unchanged 47,630 0 (0.0%) < 0.01% $282,446 2025-11-14
Q2 2025 Reduced 47,630 -1,675,371 (-97.2%) < 0.01% $358,654 2025-08-14
Q1 2025 Reduced 1,723,001 -288,524 (-14.3%) < 0.01% $13,043,118 2025-05-15
Q4 2024 Added 2,011,525 +157,115 (8.5%) < 0.01% $24,500,375 2025-02-12
Q3 2024 Added 1,854,410 +125,865 (7.3%) 0.01% $31,042,823 2024-11-14
Q2 2024 Added 1,728,545 +1,695,345 (5106.5%) 0.01% $30,145,825 2024-08-14
Q1 2024 Reduced 33,200 -10,180 (-23.5%) < 0.01% $565,728 2024-05-14
Q4 2023 Reduced 43,380 -360 (-0.8%) < 0.01% $442,042 2024-02-14
Q3 2023 Unchanged 43,740 0 (0.0%) < 0.01% $395,847 2023-11-14
Q2 2023 Added 43,740 +11,040 (33.8%) < 0.01% $470,642 2023-08-15
Q1 2023 Added 32,700 +4,500 (16.0%) < 0.01% $334,521 2023-05-15
Q4 2022 Added 28,200 +1,500 (5.6%) < 0.01% $297,510 2023-02-15
Q3 2022 Added 26,700 +2,400 (9.9%) < 0.01% $342,000 2022-11-15
Q2 2022 Added 24,300 +10,200 (72.3%) < 0.01% $312,000 2022-08-15
Q1 2022 Reduced 14,100 -1,800 (-11.3%) < 0.01% $148,000 2022-05-13
Q4 2021 Added 15,900 +2,100 (15.2%) < 0.01% $245,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

83 managers reported CULLINAN ONCOLOGY INC for Q4 2021.

Managers reporting CULLINAN ONCOLOGY INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BIOIMPACT CAPITAL LLC Unchanged 7,648,268 0 21.51% $118,013,000 4 qtrs
BVF INC IL Added 5,369,459 +4,634,353 3.01% $82,851,000 4 qtrs
CHI Advisors LLC Added 2,476,720 +231,879 12.68% $38,215,000 4 qtrs
VANGUARD GROUP INC Added 2,366,808 +85,357 < 0.01% $36,520,000 4 qtrs
BlackRock Inc Added 1,839,112 +209,518 < 0.01% $28,379,000 4 qtrs
BAUPOST GROUP LLC MA Reduced 1,535,560 -300,000 0.22% $22,509,000 4 qtrs
EVENTIDE ASSET MANAGEMENT LLC Unchanged 1,440,145 0 0.28% $21,665,000 4 qtrs
American International Group Inc Reduced 1,237,464 -413 0.1% $19,094,000 4 qtrs
Nextech Invest Ltd New 1,221,145 +1,221,145 4.96% $18,842,000 1 qtr
STATE STREET CORPORATION Added 1,175,363 +812,404 < 0.01% $18,136,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
15,900
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.